Post by Parexel

Important conversations in hematology start with strong evidence. Our experts are proud to share research at EHA 2026 exploring real-world outcomes, comparative effectiveness, regulatory considerations and innovative methodologies across a range of hematologic diseases. From CAR-T cell therapies and bispecific antibodies to sickle cell disease, multiple myeloma and mantle cell lymphoma, these posters highlight the power of real-world data and scientific rigor in advancing hematology research and development. We're excited to contribute to the conversations shaping the future of hematology and to share these insights with the broader scientific community. #EHA2026 #Hematology #RealWorldEvidence #ClinicalResearch